Prodromal PD – Fact or fiction?
“While the diagnosis of Parkinson’s disease (PD) remains focused on motor symptoms, the underlying pathological process clearly starts many years before these overt signs” began Dr Alastair Noyce (Queen Mary University London). In this ‘prediagnostic’ phase, a diverse range of non-motor and motor features can occur with a wealth of evidence now [...]
How can we target the disease mechanisms in Parkinson’s disease?
“There is currently a great deal of research being conducted on Parkinson’s disease. The Cure Parkinson’s Trust is involved in 17 trials and patients are desperate for information” stated Dr Simon Stott of The Cure Parkinson’s Trust. PD is a multifactorial disease, where both genetic and environmental factors are involved, and this provides a smorgasbord [...]
Non-pharmacological therapies: An evidence free zone?
Current medical management is only partially effective in controlling the symptoms and signs of Parkinson’s disease (PD). Medication mainly targets impairments related to dopaminergic lesions and is, therefore, not effective for symptoms that are largely related to non-dopaminergic lesions, such as impaired balance or dementia. Consequently, even with [...]
Double Dutch – Case presentation by Prof Bas Bloem
Using a series of cases, Professor Bastiaan Bloem (Director, Parkinson Center, Nijmegen, The Netherlands) underscored the importance of clinical observation in his daily practice. The first case was of a professional violinist whose tremor resulted in him retiring from his passion.1 Professor Bloem explained that this patient typically increased his [...]
Has Parkinson’s treatment really changed?
Back in June the Parkinson’s Academy hosted “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma. Now in its second year the meeting was a sell-out again and expectations were high. Chaired by Dr Peter Fletcher (Gloucestershire Hospitals NHS Foundation Trust), the meeting was designed to cater to the diverse needs […]
Drug recall for Parkinson’s and epilepsy
This week, three drugs used to treat aspects of Parkinson’s and epilepsy were recalled following concerns that the medicines had been improperly stored prior to reaching patients. The drugs in question, Neupro, Vimpat and Clexane with a B & S Healthcare label, have been recalled by the Medicines and Healthcare products Regulatory Agency (MHRA) as […]
Early research suggests groundbreaking changes afoot for Parkinson’s
Parkinson’s is a neurological condition that affects many elements of day to day functionality, changing a person’s experience of their everyday life. One of these elements is movement, with freezing, stumbling and falling all common symptoms of Parkinson’s. A recent pilot study in Canada has seen some radical changes in patient’s walking, resulting from electrical […]
Getting prepped – where will your project take you?
The Neurology Academy’s unique blend of education puts a heavy emphasis on the practical, and integral to our Parkinson’s Advanced MasterClasses is the inter-module project. For some this can be an exciting opportunity to get stuck into an audit, or service development project that they have been waiting impatiently to carry out, but for others it […]
Brain Awareness Week 2019: Parkinson’s disease
Brain Awareness Week (BAW) coordinated by the Dana Foundation, is an opportunity for partners around the globe to share their research and educate people of all ages and backgrounds about the brain and the promise of brain research. The Neurology Academy, as neurological educators, are keen to cover as broad a picture of a condition […]
What’s next in Research Engagement? You tell us!
6th December 2018 saw the Parkinson’s Academy team up with The Cure Parkinson’s Trust for our first ever dedicated research engagement. The highly-rated event covering a range of topics from the getting a project off the ground to the challenges faced, from engaging people with Parkinson’s to ensuring a project is deliverable. Established and reputable […]
